Bioceres Crop Solutions C... (BIOX)
Bioceres Crop Solutions Statistics
Share Statistics
Bioceres Crop Solutions has 62.71M shares outstanding. The number of shares has increased by -0.19% in one year.
| Shares Outstanding | 62.71M |
| Shares Change (YoY) | -0.19% |
| Shares Change (QoQ) | -0.23% |
| Owned by Institutions (%) | 19.91% |
| Shares Floating | 33.36M |
| Failed to Deliver (FTD) Shares | 29.96K |
| FTD / Avg. Volume | 9.69% |
Short Selling Information
The latest short interest is 584.33K, so 0.93% of the outstanding shares have been sold short.
| Short Interest | 584.33K |
| Short % of Shares Out | 0.93% |
| Short % of Float | 1.75% |
| Short Ratio (days to cover) | 3.55 |
Valuation Ratios
The PE ratio is 215.64 and the forward PE ratio is 12.84. Bioceres Crop Solutions's PEG ratio is -2.6.
| PE Ratio | 215.64 |
| Forward PE | 12.84 |
| PS Ratio | 1.5 |
| Forward PS | 0.4 |
| PB Ratio | 2.23 |
| P/FCF Ratio | 36.94 |
| PEG Ratio | -2.6 |
Enterprise Valuation
Bioceres Crop Solutions has an Enterprise Value (EV) of 925.88M.
| EV / Sales | 1.99 |
| EV / EBITDA | 16.7 |
| EV / EBIT | 22.19 |
| EV / FCF | 48.9 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.86.
| Current Ratio | 1.24 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | 4.89 |
| Debt / FCF | 14.31 |
| Interest Coverage | 1.67 |
Financial Efficiency
Return on Equity is 1.03% and Return on Invested Capital is 4.23%.
| Return on Equity | 1.03% |
| Return on Assets | 0.38% |
| Return on Invested Capital | 4.23% |
| Revenue Per Employee | $1.16M |
| Profits Per Employee | $8.11K |
| Employee Count | 400 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.24 |
Taxes
| Income Tax | 3.78M |
| Effective Tax Rate | 37.65% |
Stock Price Statistics
The stock price has increased by -66.93% in the last 52 weeks. The beta is 0.6, so Bioceres Crop Solutions's price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | -66.93% |
| 50-Day Moving Average | 5.11 |
| 200-Day Moving Average | 7.61 |
| Relative Strength Index (RSI) | 41.99 |
| Average Volume (20 Days) | 309.12K |
Income Statement
In the last 12 months, Bioceres Crop Solutions had revenue of 464.83M and earned 3.24M in profits. Earnings per share was 0.05.
| Revenue | 464.83M |
| Gross Profit | 181.59M |
| Operating Income | 44.82M |
| Net Income | 3.24M |
| EBITDA | 55.46M |
| EBIT | 34.16M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 44.47M in cash and 270.95M in debt, giving a net cash position of -226.47M.
| Cash & Cash Equivalents | 44.47M |
| Total Debt | 270.95M |
| Net Cash | -226.47M |
| Retained Earnings | -10.66M |
| Total Assets | 835.2M |
| Working Capital | 94.9M |
Cash Flow
In the last 12 months, operating cash flow was 41.72M and capital expenditures -22.78M, giving a free cash flow of 18.93M.
| Operating Cash Flow | 41.72M |
| Capital Expenditures | -22.78M |
| Free Cash Flow | 18.93M |
| FCF Per Share | 0.3 |
Margins
Gross margin is 39.07%, with operating and profit margins of 9.64% and 0.7%.
| Gross Margin | 39.07% |
| Operating Margin | 9.64% |
| Pretax Margin | 2.16% |
| Profit Margin | 0.7% |
| EBITDA Margin | 11.93% |
| EBIT Margin | 9.64% |
| FCF Margin | 4.07% |
Dividends & Yields
BIOX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 0.46% |
| FCF Yield | 2.71% |
Analyst Forecast
The average price target for BIOX is $10, which is 135.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 135.8% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 1.07 |
| Piotroski F-Score | 7 |